Company profilePharmaceutical#418 of 1,318 in Pakistan✓ No DRAP alerts

Pharmasol (Pvt) Ltd. DML: 000872

Pharmaceutical company · 38 brands · 90 molecules

Ranked #8 of 13 companies in Corticosteroids, Systemic Use

38 registered products 12 pharmaceutical brands 90 distinct molecules 0 DRAP alerts

Company overview

38
registered products
12
pharmaceutical brands
90
distinct molecules
7
therapeutic classes
0
DRAP alerts

Pharmasol (Pvt) Ltd. DML: 000872 is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 38 product registrations across 90 distinct molecules. Its portfolio is concentrated in Corticosteroids, Systemic Use and Other Anti-Baterials. It has no DRAP recall, shortage or safety notices on record.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Top molecules by brand count

Cefepime2 brands
Cholecalciferol ...... 5 Mg1 brand
Elemental Iron ...... 40 Mg1 brand
Nutritional Supplement / Multivitamin1 brand
Bisoprolol1 brand
Bisoprolol ...... 10 Mg1 brand
Bisoprolol ...... 5 Mg1 brand
Cephalexin1 brand

Therapeutic classes

Corticosteroids, Systemic Use · 1Other Anti-Baterials · 1Other Beta-Lactam, Cephalosporins & Penems · 1Antiemetics & Antinauseants · 1Macrolides, Lincosamides And Streptogramins · 1Quinolone Antibacterials · 1Gonadotropins And Other Ovulation Stimulants · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official53 products · Rs 20.91 – Rs 122,797.93
Median across source: Rs 638.91

Regulatory record

No DRAP alerts on record

No recalls, shortage notices or safety alerts involving this company’s products appear in the DRAP alert feed we track. Median across all 1,318 mapped companies is zero — 1,165 of them also have a clean sheet.

Competitive set

Companies whose registered portfolio overlaps most with this one.

Get the full profile for Pharmasol

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.